183 research outputs found
Non-destructive techniques for structural characterization of cultural heritage: A pilot case study
n/
Analysis of the knowledge and satisfaction with applied behavior analysis as treatment for autism spectrum disorder in parents with affected, with healthy children and childless adults
OBJECTIVE: Applied Behavior Analysis (ABA) is an evidence-based approach for the treatment of Autism Spectrum Disorder (ASD). Erroneous beliefs deriving from a reductive conception of ABA partly explain the delay in the spread of ABA treatments in Italy. Nevertheless, an increasing number of parents have been choosing this treatment. The purpose
of this survey is to investigate beliefs about ABA, the degree of satisfaction regarding ABA treatments, and the sources of information used to choose the treatment.
DESIGN: The sample included 109 Italian participants: 67 parents of children with ASD, 19 parents of healthy children and 23 adults without children. Participants have been invited to complete an online questionnaire. Socio-demographic data was also collected, along with information on the sources consulted to choose a treatment and on the satisfaction
for ABA treatments.
RESULTS: Participants agree that ABA is an approach of choice that intervenes on socially significant skills, while they do not agree with several reductive and stereotypical statements related to it. Regarding the sources, most parents with children with ASD choose the consultation with other parents who live or have lived the same experience. Finally, although the majority of participants rate ABA treatments positively, findings proved that parents of children with ASD appreciate ABA treatments more than the other two groups.
CONCLUSION: There is a broad agreement among participants in correctly identifying the distinctive features of ABA. This data indicates a certain diffusion of correct knowledge and a lower adherence to reductive concepts. The direct experience of applying ABA treatments emerges as an important variable for their positive evaluation. Even though
treatment information is more accessible compared to the past, the tendency to seek advice from other parents of children with ASD remains. The results of the survey enable us to give concrete indications for training and dissemination activities
Changes in personality factors, locus of control and creativity after a Theater-therapy intervention. Preliminary data
OBJECTIVE: The study assessed whether Theater-therapy based on Grotowski's method can improve creativity, internal locus of control and personality by promoting personal wellbeing. This study investigates the effects of Theater-therapy on: 1) personality, according to the Big five Theory; 2) internal locus of control; 3) verbal and figural creativity.
DESIGN: Eight adults took part in a 6-month intervention based on Theater-therapy and were administered the following tests at the beginning and at the end of the activity: Big five questionnaire, Locus of control scale, Torrance test of creative thinking.
RESULTS: The results showed an increase in all personality factors of Big Five, a more internal Locus of control, and an increase in creativity in the dimensions of fluidity, elaboration, originality and flexibility.
CONCLUSION: Our study suggests that Theater-therapy can be regarded as a tool promoting well-bein
Seasonal variations in antioxidant compounds of <i>Olea europaea</i> leaves collected from different Italian cultivars
The objectives of this research were to study the best conditions for phenol extraction from olive tree leaves and to evaluate the content of phenolics and the antioxidant activity by in vitro assays in olive leaves harvested in different periods from four different Italian cultivars. The results showed that leaves/solvent ratio and temperature showed a significant and positive correlation with phenol extraction yield. In all harvesting periods the phenol content of Dolce Agogia samples was higher (P ≤ 0.05) with respect to Moraiolo, Leccino and Frantoio samples. The results of analysis by high-performance liquid chromatography coupled with diode array detector (HPLC-DAD) showed that Dolce Agogia had the highest concentrations of hydroxytyrosol and oleuropein. Moreover the highest contents of bioactives have been found in olive leaves harvested in December and March. In these months, corresponding to olive harvest and pruning of olive trees, leaves represent a waste product and this interesting result could be useful in the production of nutraceuticals
CAVEOLIN-1 expression in brain metastasis from lung cancer predicts worse outcome and radioresistance, irrespective of tumor histotype
CYP2D6 genotypes in revolving door patients with bipolar disorders: A case series
RATIONALE: In psychiatric disorders, interindividual differences in cytochrome P450 (CYP)2D6 (CYP2D6) enzymatic activity could be responsible of adverse drug reactions (ADRs) and therapeutic failures (TFs) for CYP2D6-metabolized drugs, contributing to the periodical hospital readmissions of the revolving door (RD) condition.PATIENT CONCERNS: We investigated CYP2D6 genotypes in a controlled series of 5 consecutive RD patients with Bipolar Disorder (BD).DIAGNOSES: Psychiatric patients affected by Bipolar Disorder.INTERVENTIONS: We defined TFs as a difference at the Brief Psychiatric Rating Scale score \u394BPRS\u200a<\u200a25% at each 1-week of stable treatment, and ADRs as the onset of extrapyramidal symptoms and/or metabolic impairment with weight gain.OUTCOMES: At 3 months, a mean number of 2.75\u200a\ub1\u200a1.26 ADR and a mean \u394BPRS score of 16.07\u200a\ub1\u200a0.05% were observed. At 6 months of follow-up, compared to the only patient without BD (\u394BPRS\u200a<\u200a32.10%), BD patients (n\u200a=\u200a4) showed TFs (\u394BPRS\u200a<\u200a25%). CYP2D6 genotyping revealed intermediate metabolizer phenotypes for BD patients and an extensive metabolizer phenotype for the patient without BD. In BD patients, the ratio of drugs maintained/discontinued for TFs or ADRs was 1.75 for non-CYP2D6 versus 0.33 for CYP2D6 interacting drugs, while the proportion of ADR:TF was 0:4 versus 6:3.LESSONS: Our findings may suggest that CYP2D6 clinically relevant genotypes may be involved in the unwanted outcomes observed in RD patients with BD
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome
We recently described a unique plasma metabolite profile in subjects with pediatric acute-onset neuropsychiatric syndrome (PANS), suggesting pathogenic models involving specific patterns of neurotransmission, neuroinflammation, and oxidative stress. Here, we extend the analysis to a group of patients with autism spectrum disorder (ASD), as a consensus has recently emerged around its immune-mediated pathophysiology with a widespread involvement of brain networks. This observational case-control study enrolled patients referred for PANS and ASD from June 2019 to May 2020, as well as neurotypical age and gender-matched control subjects. Thirty-four PANS outpatients, fifteen ASD outpatients, and twenty-five neurotypical subjects underwent physical and neuropsychiatric evaluations, alongside serum metabolomic analysis with 1H-NMR. In supervised models, the metabolomic profile of ASD was significantly different from controls (p = 0.0001), with skewed concentrations of asparagine, aspartate, betaine, glycine, lactate, glucose, and pyruvate. Metabolomic separation was also observed between PANS and ASD subjects (p = 0.02), with differences in the concentrations of arginine, aspartate, betaine, choline, creatine phosphate, glycine, pyruvate, and tryptophan. We confirmed a unique serum metabolomic profile of PANS compared with both ASD and neurotypical subjects, distinguishing PANS as a pathophysiological entity per se. Tryptophan and glycine appear as neuroinflammatory fingerprints of PANS and ASD, respectively. In particular, a reduction in glycine would primarily affect NMDA-R excitatory tone, overall impairing downstream glutamatergic, dopaminergic, and GABAergic transmissions. Nonetheless, we found metabolomic similarities between PANS and ASD that suggest a putative role of N-methyl-D-aspartate receptor (NMDA-R) dysfunction in both disorders. Metabolomics-based approaches could contribute to the identification of novel ASD and PANS biomarkers
Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins
Extracellular vesicles (EVs) play a central role in neurodegenerative diseases (NDs) since they may either spread the pathology or contribute to the intracellular protein quality control (PQC) system for the cellular clearance of NDs-associated proteins. Here, we investigated the crosstalk between large (LVs) and small (SVs) EVs and PQC in the disposal of TDP-43 and its FTLD and ALS-associated C-terminal fragments (TDP-35 and TDP-25). By taking advantage of neuronal cells (NSC-34 cells), we demonstrated that both EVs types, but particularly LVs, contained TDP-43, TDP-35 and TDP-25. When the PQC system was inhibited, as it occurs in NDs, we found that TDP-35 and TDP-25 secretion via EVs increased. In line with this observation, we specifically detected TDP-35 in EVs derived from plasma of FTLD patients. Moreover, we demonstrated that both neuronal and plasma-derived EVs transported components of the chaperone-assisted selective autophagy (CASA) complex (HSP70, BAG3 and HSPB8). Neuronal EVs also contained the autophagy-related MAP1LC3B-II protein. Notably, we found that, under PQC inhibition, HSPB8, BAG3 and MAP1LC3B-II secretion paralleled that of TDP-43 species. Taken together, our data highlight the role of EVs, particularly of LVs, in the disposal of disease-associated TDP-43 species, and suggest a possible new role for the CASA complex in NDs
Clinical Study Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
Background. The rs12979860 CC genotype of the interleukin 28B (IL28B) polymorphism is associated with high rates of sustained virological response (SVR) to peginterferon (PegIFN) and ribavirin (Rbv) in hepatitis C virus genotype-1 (HCV-1) patients. The impact of baseline predictors of treatment outcome and their interplay with viral kinetics in HCV-1 CC patients has not been fully evaluated. Aim. To identify baseline and on-therapy predictors of treatment failure in HCV-1 IL28B CC patients. Methods. Treatment-naïve HCV-1 patients, compliant to PegIFN and Rbv who did not discontinue treatment for nonvirological reasons, were analyzed. Results. 109 HCV-1 IL28B CC were studied. Sixty were males, 39 with BMI >25, 69 with >600,000 IU/mL HCV RNA, 15 with HCV1a, and 30 with cirrhosis. Overall, 75 (69%) achieved an SVR; cirrhosis was the only baseline predictor of treatment failure (OR: 2.58, 95% CI: 1.07-6.21) as SVR rates were 53% in cirrhotics versus 75% in noncirrhotics ( = 0.03). HCV RNA undetectability (<50 IU/mL) at week 4 (RVR) was achieved by 58 patients (53%). The SVR rates were independent of RVR in noncirrhotics, 76% (34/45) RVR (+) and 74% (25/34) RVR (−) ( = 0.9). In cirrhotic patients, SVR rates were significantly higher in RVR (+) compared to RVR (−) (10/13 (77%) versus 6/17 (35%) = 0.03). Conclusions. In HCV-1 IL28B CC patients, cirrhosis is the only clinical baseline predictor of PegIFN and Rbv treatment failure. However, in IL28B CC cirrhotics, the achievement of RVR identifies those patients who still have high rates of SVR to Peg-IFN/Rbv therapy
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin
Limited therapeutic options are available for advanced colorectal cancer (CRC). Herein, we report that exposure to a neo-synthetic bis(indolyl)thiazole alkaloid analog, nortopsentin 234 (NORA234), leads to an initial reduction of proliferative and clonogenic potential of CRC sphere cells (CR-CSphCs), followed by an adaptive response selecting the CR-CSphC-resistant compartment. Cells spared by the treatment with NORA234 express high levels of CD44v6, associated with a constitutive activation of Wnt pathway. In CR-CSphC-based organoids, NORA234 causes a genotoxic stress paralleled by G2-M cell cycle arrest and activation of CHK1, driving the DNA damage repair of CR-CSphCs, regardless of the mutational background, microsatellite stability, and consensus molecular subtype. Synergistic combination of NORA234 and CHK1 (rabusertib) targeting is synthetic lethal inducing death of both CD44v6-negative and CD44v6-positive CRC stem cell fractions, aside from Wnt pathway activity. These data could provide a rational basis to develop an effective strategy for the treatment of patients with CRC
- …